Literature DB >> 20659978

Pressure ulcers in cancer palliative care patients.

I Hendrichova1, M Castelli, C Mastroianni, M Piredda, F Mirabella, L Surdo, M G De Marinis, T Heath, G Casale.   

Abstract

Terminally ill cancer patients are considered at high risk for pressure ulcers because of their clinical condition. However, in Italy, data about pressure ulcers and their prevalence are insufficient. This paper reports a study on pressure ulcers incidence and prevalence in a population of oncology patients cared for in an Italian palliative care service. A retrospective analysis of 414 clinical records of patients admitted over 6 months showed a prevalence of pressure ulcers of 22.9% and an incidence of 6.7%. Karnofsky Performance Scale Index scores, age and length of the stay were significantly related to the pressure sore development. These results support the need to focus attention on pressure ulcers prevention and treatment in terminally ill cancer patients, and to further define specific guidelines aimed at warranting patients' comfort and quality of life.

Entities:  

Mesh:

Year:  2010        PMID: 20659978     DOI: 10.1177/0269216310376119

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  3 in total

1.  Incidence of hospital-acquired pressure ulcers - a population-based cohort study.

Authors:  Joseph C Gardiner; Philip L Reed; Joseph D Bonner; Diana K Haggerty; Daniel G Hale
Journal:  Int Wound J       Date:  2014-12-03       Impact factor: 3.315

2.  Burden and outcomes of pressure ulcers in cancer patients receiving the kerala model of home based palliative care in India: results from a prospective observational study.

Authors:  Biji M Sankaran; Santam Chakraborty; Vijay M Patil; Sindhu N Raghavan; Shibimol Thomas; Subhradev Sen
Journal:  Indian J Palliat Care       Date:  2015 May-Aug

3.  Nurses' decision-making about cancer patients' end-of-life skin care in Wales: an exploratory mixed-method vignette study protocol.

Authors:  Ray Samuriwo; Candida Lovell-Smith; Sally Anstey; Claire Job; Jane Hopkinson
Journal:  BMJ Open       Date:  2020-07-05       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.